(Updated - August 24, 2022 4:47 PM EDT)

Stifel analyst Dae Gon Ha upgraded Verve Therapeutics (NASDAQ: VERV) from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE